Bisolvon.
D000814:Aniline Compounds / Q000627:therapeutic use*; D000818:Animals; D005100:Expectorants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011817:Rabbits; D013183:Sputum / Q000187:drug effects; D014050:Toluene / Q000627:therapeutic use*; D014783:Viscosity
D000814:Aniline Compounds; D005100:Expectorants; D014050:Toluene